Kidney Neoplasms: all 973 studies
Page 6 of 10. Open to participants first (214), then studies with results posted, then the rest; newest registration first within each.
- Behavioral Weight Loss Program for Cancer Survivors in MarylandCompletedNCT04534309Not applicable
- A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal CancerActive, not recruitingNCT04523272Phase 3
- TTX-080 HLA-G Antagonist in Subjects With Advanced CancersActive, not recruitingNCT04485013Phase 1
- A Study of DC-CIK Immunotherapy in the Treatment of Solid TumorsStatus unknownNCT04476641Phase 2
- Participant Reported Outcomes and Treatment Experiences in Kidney CancerCompletedNCT04472663
- Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal CarcinomasCompletedNCT04415697
- Image Guided RFA/MWA/CRYO of RCC Biomarker Profile StudyStatus unknownNCT04392076
- Does the Use of Hemostatic Clips During the Tumor Resection Step Reduce Blood Loss During Robot-assisted Partial Nephrectomy?CompletedNCT04388917
- Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell CarcinomaStatus unknownNCT04385654Phase 2
- Cellular Immunity and Renal Cell CancerCompletedNCT04377113
- Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid TumorsCompletedNCT04374877Phase 1
- To Establish a Reproducible Organoid Culture Model With Human Kidney CancerCompletedNCT04342286
- A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Surgical Planning and Intra-operative Navigation for NephrectomyCompletedNCT04329767
- CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase InhibitionActive, not recruitingNCT04322955Phase 2
- Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell CarcinomaCompletedNCT04316520Not applicable
- KIDSTAGE- Staging of Kidney Cancer Using Dual Time PET/CT and Other BiomarkersCompletedNCT04295174
- Trial of NanoDoce Intratumoral Injection in Renal Cell CarcinomaWithdrawnNCT04260360Phase 1
- Hyperpolarized 13C Pyruvate MRI Scan in Predicting Tumor Aggressiveness in Patients With Renal TumorsActive, not recruitingNCT04258462Phase 2
- Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC)CompletedNCT04222374
- Laparoscopic Partial Nephrectomy for cT1 TumorsCompletedNCT04213157
- Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney CancerCompletedNCT04180774Phase 1/2
- Effect of Papaverine on Renal Artery Blood Flow VolumeCompletedNCT04162834Phase 4
- Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid TumorsCompletedNCT04157985Phase 3
- Appropriate Dosing to Optimise Personalised Cancer TreatmentsCompletedNCT04154163
- Breathomics as Predictive Biomarker for Checkpoint Inhibitor ResponseCompletedNCT04146064
- Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR StudyCompletedNCT04134390Phase 2
- Low-moderate Intensity Pedaling During Immunotherapy AdministrationWithdrawnNCT04127318Not applicable
- ESP Block for Laparoscopic Nephrectomy SurgeriesTerminatedNCT04085237Not applicable
- Evaluation of the Reproducibility of Ablation Volumes at One Month After Microwave Treatment Compared to the Manufacturer's Abacus: on the Kidney, Liver and LungCompletedNCT04072224
- SPECT/CT for the Characterization of Renal MassesActive, not recruitingNCT03996850
- Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery for Renal Tumor.WithdrawnNCT03943771Not applicable
- MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the TumourStatus unknownNCT03934827Phase 1
- Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA MarkerTerminatedNCT03927573Phase 1
- The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT03896958
- Personal Web Page In Clinical Trial Participant EducationCompletedNCT03887091Not applicable
- Development of a Cabozantinib (Cabometyx) Symptom Management Application for Use in Patients With Renal CancerTerminatedNCT03867045Not applicable
- Mind-Body Health in Uro-Oncology: Research StudyCompletedNCT03852030Not applicable
- Open vs Robotic Assisted Partial NephrectomyTerminatedNCT03849820Not applicable
- Impact of Sunitinib Bioavailability on Toxicity and Treatment Efficacy in Patients Treated for Metastatic Renal CancerTerminatedNCT03846128
- GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal MassesCompletedNCT03819569Not applicable
- 3D-biomodels for Surgical Planning in Patients With Renal Cancer and Vascular InvolvementStatus unknownNCT03738488Not applicable
- A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal CarcinomaStatus unknownNCT03736330Phase 2
- A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint InhibitorsActive, not recruitingNCT03693014Phase 2
- Zero-ischemia Robot-assisted Partial Nephrectomy Using Near-infrared FluorescenceStatus unknownNCT03679572Not applicable
- 9-ING-41 in Patients With Advanced CancersActive, not recruitingNCT03678883Phase 2
- A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has SpreadCompletedNCT03663946
- Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsCompletedNCT03662204
- Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and PartnersTerminatedNCT03652298Phase 2
- Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesStatus unknownNCT03638206Phase 1/2
- A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)Active, not recruitingNCT03634540Phase 2
- Safety and Compliance of Renal Cancer Patients Treated by Non-IV DrugsStatus unknownNCT03630692
- BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)Status unknownNCT03628859
- Optimizing the Management of Patients With Oral TherapyTerminatedNCT03623490Not applicable
- Improved Assessment of Response in Metastatic Renal Cell Carcinoma Using Spectral-CTStatus unknownNCT03616951
- 3D Virtual Models as an Adjunct to Preoperative Surgical PlanningCompletedNCT03606044
- Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal TumorsStatus unknownNCT03571438Not applicable
- Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer ParticipantsCompletedNCT03568435
- 89Zr-girentuximab ) Dosimetry in CCRC Study - ZIR-DOSECompletedNCT03556046Phase 1
- Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney CancerWithdrawnNCT03540199Phase 2
- Patient-Centered Communication of Life Expectancy Estimates in Genitourinary MalignanciesStatus unknownNCT03522155Not applicable
- Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone MetastasesCompletedNCT03520231Phase 2
- Effects of Anesthesia on Immunity in CancerCompletedNCT03514550Phase 4
- Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney CancerCompletedNCT03473730Early Phase 1
- Multiparametric MRI for Diagnosing Small Renal TumorsCompletedNCT03470285Not applicable
- Nivolumab Plus Stereotactic Body Radiotherapy in II and III Line of Patients With Metastatic Renal Cell CarcinomaCompletedNCT03469713Phase 2
- Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study)TerminatedNCT03456401Phase 2
- Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney CancerCompletedNCT03455452
- Dynamic Measurement of Renal Functional Reserve as a Predictor of Long-Term Renal FunctionStatus unknownNCT03442647Not applicable
- Study of the Concentration-effect Relationship of Nivolumab in Patients With Kidney or Lung CancerCompletedNCT03433534
- Efficacy and Safety of Systemic Treatments of Bone Metastases From Kidney Cancer in Patients Treated With Targeted TherapiesTerminatedNCT03408652Phase 3
- Robot-assisted Surgical Resection vs. Cryoablation of Localised Renal CancerWithdrawnNCT03390413Not applicable
- Mix Vaccine for Metastatic Kidney CancerCompletedNCT03357289Phase 1/2
- Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial NephrectomyCompletedNCT03323021Not applicable
- Study of Durvalumab and Guadecitabine in Advanced Kidney CancerActive, not recruitingNCT03308396Phase 1/2
- Genomic Testing and Resulting Medical DecisionsCompletedNCT03301493
- RObotic PArtial Nephrectomy National StudyCompletedNCT03292549
- A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsCompletedNCT03289962Phase 1
- Denosumab and Pembrolizumab in Clear Cell Renal CarcinomaStatus unknownNCT03280667Phase 2
- The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial NephrectomyCompletedNCT03273751Not applicable
- Study of the Variations of the Blood Pressure After Nephrectomy for Renal Cancer (VAPANCR)Status unknownNCT03218319Not applicable
- Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell CarcinomasWithdrawnNCT03189186Phase 1
- Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic AgentsActive, not recruitingNCT03185039Not applicable
- Study to Assess the Safety of Nivolumab in the Treatment of Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Chronic Hodgkin Lymphoma in Adults in MexicoWithdrawnNCT03161613
- Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) CancersTerminatedNCT03134027
- Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)CompletedNCT03133286
- Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibitors of VEGFR) - mTOR- Axitinib Inhibitors or Anti-VEGF Antibody -Inhibiteurs mTOR - AxitinibStatus unknownNCT03129724
- ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to SunitinibCompletedNCT03097601
- Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and MelanomaStatus unknownNCT03086174Phase 1
- Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal CancerCompletedNCT03073395Phase 1
- Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment.CompletedNCT03066427Phase 2
- The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major SurgeryCompletedNCT03064308Not applicable
- Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell CarcinomaStatus unknownNCT03062410Not applicable
- Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell CarcinomaWithdrawnNCT03035630Phase 2
- A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)Active, not recruitingNCT02974738Phase 1
- A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney CancerCompletedNCT02960906Phase 2
- NeoVax Plus Ipilimumab in Renal Cell CarcinomaActive, not recruitingNCT02950766Phase 1
- Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.CompletedNCT02947165Phase 1
- Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer PatientsCompletedNCT02946671Phase 1
- Minocycline Attenuate Postoperative Cognitive Dysfunction and DeliriumStatus unknownNCT02928692Phase 3
- Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial NephrectomyCompletedNCT02924922Not applicable